טוען...
Understanding silibinin’s modes of action against HCV using viral kinetic modeling
BACKGROUND & AIMS: Legalon® SIL (SIL) is a chemically hydrophilized version of silibinin that has exhibited high antiviral effectiveness against hepatitis C virus (HCV). Its main mode of action (MOA) remains unclear, with contradicting in-vitro studies supporting either suppression of entry and...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3328661/ https://ncbi.nlm.nih.gov/pubmed/22245888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2011.12.012 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|